Zentralbl Chir 2021; 146(S 01): S53
DOI: 10.1055/s-0041-1733362
Abstracts

V-116 Minimally invasive thymectomy in early stage thymoma – the new standard?

N Mayer
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
P Perikleous
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
H Bruijnen
2   University Hospital Augsburg, Germany, Former Department of Vascular and Endovascular Surgery, Augsburg, Deutschland
,
S Jordan
3   Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
E Lim
3   Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
J Finch
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
E Beddow
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
V Anikin
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
,
N Asadi
1   Harefield Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, Thoracic Surgery, London, Vereinigtes Königreich
› Author Affiliations
 

Hintergrund

Minimally invasive thymectomy has been implemented with uncertain oncological outcome.

Video-assisted thoracoscopy (VATS) recently became gold-standard treatment for early stage lung cancer. Complete resection is mandatory, with excellent survival in early stages (Masaoka-Koga I+IIA/B). We aimed to show whether to consider VATS thymectomy equal to open resection regarding oncological outcome and long-term survival.



Publication History

Article published online:
06 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany